Inogen Inc at Morgan Stanley Healthcare Conference Transcript
Starting? Excellent. Good afternoon, and thank you all for sticking around on the last in the afternoon. My name is Jay Chadha. I'm part of the medical device research team here at Morgan Stanley. And we have Inogen here with us today. Scott Wilkinson, CEO; and Ali Bauerlein, CFO.
Before we begin, please take a moment to review all applicable disclosures online.
Questions & Answers
Scott, I thought maybe we could start just with on getting a better sense of the underlying market demand, there have been some challenges earlier this year across the business, and I think what investors are really trying to figure out is how strong is underlying market demand and kind of what have been kind of the puts and takes there.
Yes. Thanks. And let me start before I dive into the question, I'd
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |